Loading clinical trials...

Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation | Clinical Trials | Clareo Health

RECRUITINGNA

Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation

Examining the Relationship Between Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation in Chronic Obstructive Pulmonary Disease Patients.

NCT06217276•Istanbul Medipol University Hospital

View on ClinicalTrials.gov

Summary

In our study, changes in vastus lateralis muscle oxygenation will be evaluated with the Moxy device, a functional infrared oxygen measurement device, during the inspiratory muscle fatigue protocol in COPD cases and the healthy control group.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Having a diagnosis of Stage 2-3 COPD according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).
•Having been using the same medications for the last 4 weeks
•Being over 18 years of age
•Not having any diagnosed chronic disease
•Not being a smoker

Exclusion Criteria

•Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min).
•Presence of any vascular problem that may affect lower extremity muscle oxygenation
•Presence of another respiratory system disease other than COPD
•Patients who have had an acute COPD exacerbation in the last 4 weeks
•Patients experiencing COPD exacerbations during the study protocol
•Presence of fatty tissue or scar tissue at the measurement points, which may impair the measurement quality.
•Have already participated in another clinical trial within the last 30 days that may affect the results of the study.

Locations (1)

Yedikule Chest Disease Hospital

Istanbul, Zeytinburnu, Turkey (Türkiye)

Key Dates

Start Date

January 20, 2024

Primary Completion Date

January 15, 2026

Completion Date

January 15, 2026

Last Updated

May 1, 2025

Enrollment

ESTIMATED participants

Conditions

COPD

Interventions

Respiratory muscle fatigue protocol

OTHER

Contacts

ESRA PEHLİVAN

CONTACT

09050585279 fztesrakambur@yahoo.com

cfMSC Stem Cell Therapy Targeting COPD

NCT07477600

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGNA

Effect of Telenursing on Oral Health

NCT07462221

COPD

View study

RECRUITINGNA

Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD

NCT07351929

COPD Exacerbation

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation

Inclusion Criteria

Exclusion Criteria

cfMSC Stem Cell Therapy Targeting COPD

Effect of Telenursing on Oral Health

Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD

Probiotics in Pulmonaty Rehabilitation for COPD

Effects of Eccentric Exercise Training in Patients With COPD

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3